RT Journal Article
SR Electronic
T1 Impact of spatiotemporal heterogeneity in COVID-19 disease surveillance on epidemiological parameters and case growth rates
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.31.22273230
DO 10.1101/2022.03.31.22273230
A1 Inward, Rhys P.D.
A1 Jackson, Felix
A1 Dasgupta, Abhishek
A1 Lee, Graham
A1 Battle, Anya Lindström
A1 ,
A1 Parag, Kris V.
A1 Kraemer, Moritz U.G.
YR 2022
UL http://medrxiv.org/content/early/2022/08/16/2022.03.31.22273230.abstract
AB SARS-CoV-2 case data are primary sources for estimating epidemiological parameters and for modelling the dynamics of outbreaks. Understanding biases within case based data sources used in epidemiological analyses are important as they can detract from the value of these rich datasets. This raises questions of how variations in surveillance can affect the estimation of epidemiological parameters such as the case growth rates. We use standardised line list data of COVID-19 from Argentina, Brazil, Mexico and Colombia to estimate delay distributions of symptom-onset-to-confirmation, -hospitalisation and -death as well as hospitalisation-to-death at high spatial resolutions and throughout time. Using these estimates, we model the biases introduced by the delay from symptom-onset-to-confirmation on national and state level case growth rates (rt) using an adaptation of the Richardson-Lucy deconvolution algorithm. We find significant heterogeneities in the estimation of delay distributions through time and space with delay difference of up to 19 days between epochs at the state level. Further, we find that by changing the spatial scale, estimates of case growth rate can vary by up to 0.13 d-1. Lastly, we find that states with a high variance and/or mean delay in symptom-onset-to-diagnosis also have the largest difference between the rt estimated from raw and deconvolved case counts at the state level. We highlight the importance of high-resolution case based data in understanding biases in disease reporting and how these biases can be avoided by adjusting case numbers based on empirical delay distributions. Code and openly accessible data to reproduce analyses presented here are available.Competing Interest StatementThe authors have declared no competing interest.Funding StatementRole of the Funding Sources: M.U.G.K. is supported by The Branco Weiss Fellowship - Society in Science, administered by the ETH Zurich and acknowledges funding from a Google Faculty Award, the Oxford Martin School. This work was partially funded by the European Union Horizon 2020 project MOOD (#874850), Google.org, and the Rockefeller Foundation. The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used within this study are open source with details of how to obtain them found in the methods section.